Clinical Characteristics of Small Intestinal Bacterial Overgrowth in Individuals With Abdominal Bloating/Distention
1 other identifier
observational
387
1 country
1
Brief Summary
Abdominal bloating/distention represents a prevalent clinical manifestation characterized by an unclear etiology and pathogenesis. This symptomatology is frequently observed in various conditions, including small intestinal bacterial overgrowth (SIBO). The utilization of the breath test as a non-invasive diagnostic approach has become widespread in recent years for identifying SIBO. In this study, the prevalence of SIBO irregularities in individuals presenting with abdominal bloating/distention was ascertained through the implementation of the breath test. Furthermore, the correlation between abdominal bloating/distention and SIBO was analysed to enhance the elucidation of the underlying etiology of abdominal bloating/distention. These findings aim to offer valuable insights for refining clinical comprehension and strategies related to the diagnosis and treatment of abdominal bloating/distention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 29, 2024
CompletedStudy Start
First participant enrolled
March 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
CompletedSeptember 17, 2026
September 1, 2026
2.3 years
February 5, 2024
September 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Positive rate of SIBO in patients with abdominal bloating/distension
Detect the positive rate of SIBO in patients with abdominal bloating/distension by breath test
2024-03-01 to 2026-06-01
Secondary Outcomes (1)
Correlation between clinical features of patients with abdominal bloating/distension and SIBO
2024-03-01 to 2026-06-01
Interventions
The concentration of methane and hydrogen in the exhaled gas of patients with Abdominal bloating/distention is measured by a breath test to determine the presence of SIBO.
Eligibility Criteria
Abdominal bloating/distension patients in the outpatient department.
You may qualify if:
- Patients aged 18 to 70 years.
- Patients presenting with the primary complaint of abdominal bloating and/or abdominal distension, or those exhibiting abdominal distension with prominence over other symptoms.
You may not qualify if:
- Patients who are pregnant or lactating.
- Patients have history of gastrointestinal malignancy or gastrointestinal surgery.
- Patients manifesting food intolerance or presenting with a confirmed diagnosis or suspicion of lactose intolerance.
- Patients with urinary system (chronic kidney disease, etc.), immune system (scleroderma, etc.), nervous system (Parkinson's disease, etc.), mental system (depression, etc.), or other diseases outside the digestive system.
- Patients who used antibiotics or microecological agents or underwent endoscopic examination within two weeks.
- Patients with a medication history encompassing motility enhancers, secretory enhancers, antifoaming agents, spasmolytics, opioids, and antidepressants within the past week.
- Patients who are unwilling or incapable to provide informed consents.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Shandong Universitylead
- Jinan Central Hospitalcollaborator
- Zaozhuang Municipal Hospitalcollaborator
- Binzhou Medical Universitycollaborator
- Qihe Xian Renmin Hospitalcollaborator
- Dezhou Hospital Qilu Hospital of Shandong Universitycollaborator
- Weifang People's Hospitalcollaborator
Study Sites (1)
Gastroenterology Department of Qilu Hospital
Jinan, Shandong, 250012, China
Biospecimen
The exhaled air of the patient after taking the substrate.
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Feixue Chen, MD
Qilu Hospital of Shandong University
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor, Director of gastroenterology department of Qilu hospital
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 29, 2024
Study Start
March 1, 2024
Primary Completion
June 1, 2026
Study Completion
June 1, 2026
Last Updated
September 17, 2026
Record last verified: 2026-09